Prediction of Bacteremia in Children with Febrile Episodes During Chemotherapy for Acute Lymphoblastic Leukemia

REFERENCES

• Christensen MS, Heyman M, Möttonen M, Treatment-related deaths in childhood acute lymphoblastic leukaemia in the Nordic countries, 1992–2001. Br J Haematol. 2005;131:50–58.
   PubMed Web of Science ®Google Scholar
• Lund B, Åsberg A, Heyman M, Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2011;56:551–559.
   PubMed Web of Science ®Google Scholar
• Agyeman P, Aebi C, Girt A, Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J. 2011;30:e114–e119.
   Google Scholar
• Alexander SW, Wade KC, Hibberd PL, Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002;24:38–42.
   PubMed Web of Science ®Google Scholar
• Amman RA, Hirt A, Lüthy AR, Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2002;41:436–443.
   Google Scholar
• Amman RA, Hirt A, Lüthy AR, Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infec Dis J. 2004;23:61–67.
   PubMedGoogle Scholar
• Amman RA, Bodmer N, Hirt A, Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol. 2010;28:2008–2014.
   PubMedGoogle Scholar
• Baorta EP, Aquino VM, Mullen CA, Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92:909–913.
   PubMedGoogle Scholar
• Hakim H, Flynn PM, Srivastava DK, Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010;29:53–59.
   PubMedGoogle Scholar
• Klassen RJ, Goodman TR, Pham B, “Low-risk” prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012–1019.
   PubMedGoogle Scholar
• Madsen K, Rosenman M, Hui S, Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol. 2002;24:257–262.
   Google Scholar
• Rackoff WR, Gonin R, Robinson C, Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol. 1996;14:919–924.
   PubMed Web of Science ®Google Scholar
• Rondinelli PIP, de Cassia Braga Ribeiro K, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006;28:665–670.
   PubMed Web of Science ®Google Scholar
• Santolaya ME, Alverez AM, Becker A, Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415–3421.
   PubMed Web of Science ®Google Scholar
• Santoyola ME, Alvarez AM, Avilés CL, Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever and neutropenia. Clin Infect Dis. 2002;35:678–683.
   PubMedGoogle Scholar
• Schmiegelow K, Forestier E, Hellebostad M, Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukaemia. Leukemia. 2010;24:345–354.
   PubMed Web of Science ®Google Scholar
• Barbaric D, Curtin J, Pearson L, Role of hydrochloric acid in the treatment of central venous catheter infections in children with cancer. Cancer. 2004;101:1866–1872.
   PubMed Web of Science ®Google Scholar
• Madsen M, Rosthøj S. Impact of hydrochloric acid instillations on salvage of infected central venous catheters in children with acute lymphoblastic leukemia. Scand J Infect Dis. 2012; doi:10.3109/00365548.2012.708941.
   Google Scholar
• Mermel LA, Allon M, Bouza E, Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
   PubMed Web of Science ®Google Scholar
• Edslev PW, Rosthoj S, Treutiger I, A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic thrombocytopenic purpura in children. Br J Haematol. 2007;138:513–516.
   PubMed Web of Science ®Google Scholar
• Donato H, Picon A, Martinez M, Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina. Pediatr Blood Cancer. 2009;52:491–496.
   PubMed Web of Science ®Google Scholar
• Phillips B. Clinical decision rules: how to build them. Arch Dis Child Educ Pract Ed. 2010;95:83–87.
   PubMedGoogle Scholar